In this episode, our CEO Dr. Antonella Santuccione Chadha had the opportunity to speak about a topic that is both deeply personal and scientifically urgent: the gender differences in mental and neurological disorders affecting women.
While women live longer than men, they spend approximately 25% more of their lives with health impairments. Psychiatric and neurological conditions disproportionately affect women—depression, anxiety, eating disorders, and migraines are significantly more prevalent. ADHD is often diagnosed late, and two-thirds of those living with Alzheimer’s dementia are women. These patterns are not coincidental; they reflect a complex interplay of biology, hormones, and systemic gaps in research and care.
From puberty to menopause, women experience heightened vulnerability to brain-related disorders. Yet, gender-specific research remains underfunded and underrepresented in clinical trials. This must change.
Dr. Santuccione Chadha advocates for a future where sex and gender differences are not overlooked but embraced as essential to progress. In her recent conversation with Dr. med. Rosilla Bachmann Heinzer, they explored:
➡️ Why gender-specific preclinical and clinical research is critical
➡️ How these insights can transform pharmacotherapy and care
➡️ The importance of investing in Women’s Brain Capital—a concept that recognizes and protects women’s cognitive and emotional performance as a societal asset
Listen Now
